Company Interview / Momentum continues with this record result

Dr. Sam Hupert from Pro Medicus (ASX: PME) discuss the company's financial performance, with a 32% revenue increase and record contract wins.

He credits this success to consistent growth, price accretion, and new products. Focused on North American expansion, particularly in the US, Pro Medicus leverages its cloud-based technology and proprietary image handling to stay competitive.

Looking ahead, Sam sees potential for AI-driven M&A opportunities while remaining committed to organic growth through innovation and strategic partnerships. The company also has robust succession planning in place for continued clinical and financial success.